Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.

Antimicrobial agents and chemotherapy - 1 Jan 2016

Arendrup Maiken Cavling, Jensen Rasmus Hare, Cuenca-Estrella Manuel

Abstract excerpt

ASP2397 is a new compound with a novel and as-yet-unknown target different from that of licensed antifungal agents. It has activity against Aspergillus and Candida glabrata. We compared its in vitro activity against wild-type and azole-resistant A. fumigatus and A. terreus isolates with that of amphotericin B, itraconazole, posaconazole, and voriconazole. Thirty-four isolates, including 4 wild-type A. fumigatus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amphotericin B
Share to Aspergillosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aspergillus

Share to Aspergillus fumigatus

Share to Azoles

Share to Itraconazole

Share to Peptides, Cyclic

Share to Voriconazole

Source

Open in PubMed Open full text

Identifiers

PMID: 26552973
DOI: 10.1128/AAC.02336-15
PMCID: PMC4704222

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.PMID 26552973Read ↗

Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.Semantic proximity Read ↗

Exploring the molecular mechanism of azole resistance in Aspergillus fumigatus.Semantic proximity Read ↗

Epidemiological characteristics of invasive Aspergillus isolates: morphology, drug susceptibility, and mutations in azole drug targetsSemantic proximity Read ↗

Epidemiological characteristics of invasive Aspergillus isolates: Morphology, drug susceptibility, and mutations in azole drug targets.Semantic proximity Read ↗

Azole resistance in Aspergillus fumigatus- comprehensive review.Semantic proximity Read ↗

Medically Important Fungi Respond to Azole Drugs: An UpdateSemantic proximity Read ↗

In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.Semantic proximity Read ↗

The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back.Semantic proximity Read ↗

In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.Semantic proximity Read ↗

Phenotypic and Molecular Characterization of Three Clinical Voriconazole- Resistant Aspergillus fumigatus Isolates Harboring TR46/M143L Mutations in cyp51ASemantic proximity Read ↗

Comparative analysis of the biological characteristics and mechanisms of azole resistance of clinical Aspergillus fumigatus strainsSemantic proximity Read ↗

Fungal Drug Response and Antimicrobial ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.